DiscoverMarkets & Money Today | 2 Min News | The Daily News Now!Stock Market Mixed Results: StubHub, Bristol-Myers Squibb, Cidara, DoorDash
Stock Market Mixed Results: StubHub, Bristol-Myers Squibb, Cidara, DoorDash

Stock Market Mixed Results: StubHub, Bristol-Myers Squibb, Cidara, DoorDash

Update: 2025-11-14
Share

Description

On November fourteenth, U.S. stocks saw mixed results, with the Dow dipping slightly, S&P five hundred climbing, and Nasdaq Composite Index rising. StubHubs stock plummeted by nearly twenty-five percent, while Bristol-Myers Squibb shares fell by three point four percent after halting a heart medication trial. Cidara Therapeutics stock surged by more than double following Mercks acquisition announcement, and DoorDash stock rose by nearly seven percent, recovering from recent losses.

The Daily News Now! — Every city. Every story. AI-powered.


Hosted on Acast. See acast.com/privacy for more information.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Stock Market Mixed Results: StubHub, Bristol-Myers Squibb, Cidara, DoorDash

Stock Market Mixed Results: StubHub, Bristol-Myers Squibb, Cidara, DoorDash